Nationwide audit of cervical cancer screening reveals unsatisfactory triage strategies and trends over time in incidence among cytology negative women
Open Access
- 9 March 2026
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 159 (2) , 467-477
Abstract
Regular audits are essential for monitoring and evaluation of cervical screening. We audited the Swedish cervical screening program during the transition to HPV‐based screening using a registry‐based cohort design. In total, 5689 consecutive, confirmed cases of invasive cervical cancer between 2012 and 2022 were retrieved from the Swedish Quality Register for Gynecological Cancer. Their screening history, screening status, invitations to cervical screening, all diagnoses in screening cytology and HPV genotypes were retrieved from the Swedish National Cervical Screening Registry. Furthermore, all cancer cases during 2018–2022 were classified according to their screening history and the age‐standardized cervical cancer incidence rate stratified by screening history and calendar year was calculated among the cohort of all women in Sweden ages 29–84. Non‐participation remains the main process related history with high risk of cancer (cervical cancer incidence rate, IR, among non‐attenders was 33.9 [95% confidence intervals, 95% CI, 28.2–39.5] per 100,000 person‐years, /100,000PY, representing 31% of cases in 2022). The cervical cancer IR after negative cytology increased with calendar time (IR = 5.5 [95% CI, 4.1–6.8]/100,000PY in 2012 and 11.5 [8.1–14.9]/100,000PY in 2022) and was high after a positive HPV test followed by negative cytology triage (IR = 56.7 [39.9–73.6] in 2022). In conclusion, this comprehensive audit has identified a decreasing protection by the screening test under discontinuation (cytology) and that the performance as a triage test after HPV‐testing is unsatisfactory.Keywords
This publication has 21 references indexed in Scilit:
- Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus PrevalenceThe Journal of Infectious Diseases, 2025
- Long‐term follow‐up of cervical cancer incidence after normal cytological findingsInternational Journal of Cancer, 2023
- How Many Human Papillomavirus Types Do We Need to Screen For?The Journal of Infectious Diseases, 2020
- Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening programInternational Journal of Cancer, 2019
- Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control studyBMJ, 2019
- Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort studyBMJ, 2016
- Laboratory audit as part of the quality assessment of a primary HPV-screening programJournal of Clinical Virology, 2016
- Cervical cancer screening in Europe: Quality assurance and organisation of programmesEuropean Journal of Cancer, 2015
- Screening and cervical cancer cure: population based cohort studyBMJ, 2012
- Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in SwedenJNCI: Journal of the National Cancer Institute, 2008